LEADER 01669nam  2200469   450 
001 9910712024203321
005 20190410113936.0
035   $a(CKB)5470000002489863
035   $a(OCoLC)1096282003
035   $a(EXLCZ)995470000002489863
100   $a20190410e19901988  ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBiological vulnerability to drug abuse /$feditors: Roy W. Pickens, Dace S. Svikis
210  1$aRockville, Maryland :$cU.S. Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse,$d1990.
215   $a1 online resource (viii, 185 pages) $cillustrations
225 1 $aNIDA research monograph ;$v89
225 1 $aDHHS publication ;$vno. (ADM) 90-1590
300   $a"Printed 1988, reprinted 1990"--Page iv.
320   $aIncludes bibliographical references.
606   $aDrug abuse$zUnited States$xGenetic aspects
606   $aDrug abuse$zUnited States
606   $aBehavior genetics
606   $aPharmacogenetics$zUnited States
606   $aGenetic markers$zUnited States
615  0$aDrug abuse$xGenetic aspects.
615  0$aDrug abuse
615  0$aBehavior genetics.
615  0$aPharmacogenetics
615  0$aGenetic markers
702   $aPickens$b Roy W.
702   $aSvikis$b Dace S.
712 02$aNational Institute on Drug Abuse,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910712024203321
996   $aBiological vulnerability to drug abuse$93316086
997   $aUNINA